Work

POSTER: AML-1357 Outcomes in Acute Myeloid Leukemia With MECOM Rearrangement (MECOMr-AML) Treated With Hypomethylating Agent Plus Venetoclax

Year: 2025

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(25)00643-3

Authors: Leora Boussi, Elizabeth Corley, Andriy Derkach, Meira Yisraeli Salman, Justin Wheat, Christopher Famulare, Kuo-Kai Chin, Meghan Thompson, Sheng Cai, Eytan Stein, Yanming Zhang, Aaron Goldberg

Institutions: Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4413780731

FWCI:

Cites:

Cited by:

Related to: 10